ABSTRACT: Many HIV-infected children have neurological involvement. We present our observations in 49 cases, 58% of which had some form of clinical neurological impairment. Most of the patients affected (71%) presented with progressive encephalopathy, characterized by developmental delay with loss of acquisitions and cognitive decline, an impaired growth curve, microcephaly and corticospinal dysfunction. CT-scan imaging shows cerebral atrophy in all cases and basal ganglia calcifications in 29%. Non-specific abnormalities are found on the EEG in two-thirds of cases and in the CSF in slightly less than half the cases. Pathological studies sometime revealed HIV encephalitis or lateral corticospinal tracts degeneration. Neurological impairment secondary to vascular events, neoplasms or opportunistic infections were rare, especially when compared with the adult HIV population. RESUME: Atteinte neurologique chez les enfants infectes par le VIH : observations chez 49 patients. Un nombre important d'enfants infectes par le VIH developpent des complications neurologiques. Nous rapportons nos observations chez 49 patients. 58% avaient une atteinte neurologique clinique. La plupart des enfants affectes (71%) presentaient un tableau d'encephalopathie progressive, caracterisee par un retard de developpement avec une perte des acquisitions et une atteinte des fonctions cognitives, un retard staturo-ponderal, une microcephalic et une atteinte corticospinale. Le CT-scan a demontre une atrophie cerebrale dans tous les cas ainsi que des calcifications des noyaux gris centraux dans 29% des cas. Des anomalies non-specifiques ont ete notees a l'EEG dans deux tiers des cas et dans le LCR dans un peu moins de la moitie des cas. L'etude pathologique a parfois revele une encephalite reliee au VIH et / ou une degenerescence des faisceaux corticospinaux lateraux. Les troubles neurologiques secondaires aux atteintes vasculaires, aux neoplasies ou aux infections opportunistes demeurent nettement moins frequents que dans la population VIH adulte.
PATIENTS
Observations in 49 consecutive patients, investigated at Sainte-Justine Hospital from 1981 to 1991, were studied in a retrospective fashion. These patients were followed, most of them since birth, by one of the authors (N.L.). Consultation in neurology was obtained for all patients who presented evidence of neurological involvement, and para-clinical investigations were performed when judged necessary. Autopsy was obtained whenever possible.
The majority developed symptomatic infection, defined as P2 class according to the classification for HIV-infected children under 13 years of age. 9 Nine patients had an asymptomatic infection (PI class). No PO-class child was included in the study. One patient was born with great prematurity and died at three weeks of age. He was not included in the study and thus, 48 patients were retained in our review.
RESULTS
Forty-eight patients were studied, 36 of whom were black (32 Haitians, two Africans, two Caribbeans), 11 were Caucasian and one was Vietnamese.
Forty-six of the 48 patients contracted the disease by maternal (vertical) transmission, while the remaining two were infected by blood transfusion at a time when routine screening of blood products for HIV was not yet instituted. Twenty-five of the 46 patients were females, 21 were males. The results are summarized in Table I .
Clinical Manifestations
Twenty-eight (58%) of the 48 patients studied had symptomatic neurological impairment. Of these, 20 (71%) had THE CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES progressive encephalopathy, characterized by developmental delay with eventual loss of previous acquisitions, impaired growth and corticospinal tract dysfunction (see Table 2 ).
Most of the patients with progressive encephalopathy presented a sub-acute evolution with steady decline in cognitive and motor function. Five patients had an initial period of neuro- logical stability (plateau) with subsequent deterioration. One patient had documented improvement with catch-up growth and cognitive development for four years, before deteriorating rapidly to a demential state. Another patient had catch-up motor development for nine months before an eventual deterioration. Although variable, onset of neurological symptoms for most of these patients was in the first year of life. Seventeen of these 20 patients are deceased, at an average age of 33 months
AIDS Classification
Microcephaly was found in 55% of the 20 patients.
One patient presented initially with a clinical picture of transverse myelitis and developed signs of progressive encephalopathy 15 months later. Another patient, while suffering from progressive encephalopathy since the first year of life, presented at five years of age with clinical evidence of spinal cord dysfunction, documented by somatosensory evoked potentials.
None of the patients had movement disorder or signs of cerebellar dysfunction, nor was there any clinical evidence of peripheral involvement. Seizures were a rare feature, occurring in a non-febrile context in only two cases. Brain stem features were also infrequent (three cases).
Among the 28 patients with neurological dysfunction, three could be classified as having static encephalopathy with varying degree of developmental delay and corticospinal dysfunction and a stable evolution over a one-year period or more. Five other patients could not be classified because of a short followup period ( average four months).
Of the initial cohort (n = 48), six patients had asymptomatic neurological involvement (see Table 3 ). Despite having no neurological signs or symptoms, five of the six patients had cerebral atrophy on CT. The remaining patient had microcephaly and an impaired growth curve. Interestingly, one nine-year-old child is asymptomatic despite having cerebral atrophy and basal ganglia calcifications on the CT.
The fourteen remaining patients were free of clinical and para-clinical involvement at an average age of 40 months.
The patients' neurological status are summarized in Table 3 . One patient died of a massive ischemic stroke at four months of age. None of the patients developed neoplasms, nor was there any clinical or laboratory evidence of opportunistic infection. Two patients developed streptococcal meningitis.
Laboratory Results
Seventeen of the 20 patients with progressive encephalopathy had one or more CT scans. All of them had cerebral atrophy, cerebellar atrophy being a much less frequent feature. Five (29%) showed calcifications of the basal ganglia region. The three patients with static encephalopathy also had cerebral atrophy, but none had calcifications.
EEG was performed on nine of the 20 patients with progressive encephalopathy. Two-thirds were abnormal with non-specific diffuse slowing.
CSF studies revealed slightly increased protein (50-100 mg%) in five of 11 patients tested in the progressive encephalopathy group (see Table 4 ).
Pathological Findings
Ten of the twenty patients with progressive encephalopathy had an autopsy. Changes compatible with HIV-related encephalitis were found in four cases. These changes included inflammatory cell infiltrates, microglial nodules, and multinucleated giant cells (see Figure 1 ). These findings were also noted in a seven-month-old child not included in the progressive encephalopathy group because of early death. In another patient with progressive encephalopathy, histological studies showed signs of HIV leukoencephalopathy.
Degeneration of the lateral corticospinal tracts was noted in five of ten cases. Another case revealed a vacuolar pattern of degeneration of both the lateral corticospinal tracts and the posterior columns (see Figure 2 ). Histological evidence of CMV encephalitis was observed in two cases, and Candida Albicans encephalitis in one. DISCUSSION The presence and extent of neurological involvement in HIVinfected children varies as seen in the present day literature. 7 -810 In their published series, Epstein et al. 7 found some form of neurological involvement in 57 of 79 HIV-infected children (72%), about 60% of which was of the progressive encephalopathy type, as previously described, the other 40% taking the form of a static encephalopathy. In her review, Belman 8 cites a 50 to 62% incidence of "progressive encephalopathy" in infants and children with symptomatic HIV infection.
In our study, 58% of HIV-infected children presented with clinical neurological impairment. We believe this figure probably represents an underestimate of the true incidence. The six cases classified as having asymptomatic neurological dysfunction are understandably at high risk of eventually developing neurological clinical signs or symptoms related to HIV infection. Furthermore, the patients considered free of neurological impairment did not have systematic CT-scanning or CSF analysis. In addition, three patients with asymptomatic neurological involvement and three of the 14 patients free of neurological dysfunction were less than 15 months of age at the time of this study. Although, as previously mentioned, most of the patients became symptomatic in the first year of life, there are a number of cases, both in our series and in the literature, of initial symptoms emerging later in infancy. 7 -810 However, other factors must be taken into account when discussing cerebral atrophy in HIV infected children, such as inutero exposure to drugs." 12 Subsequent environmental conditions and educational stimuli have also been shown to be potential factors in developmental delay. 13 A three to one ratio of progressive to static encephalopathy has been suggested. 810 Although we found 71% of progressive encephalopathy among the 28 patients with clinical impairment of the central nervous system, only three cases (11%) could be classified with certitude as static encephalopathy. Whether or not these two types of encephalopathy represent different pathophysiological processes remains unclear. It has been suggested that static encephalopathy is not the result of direct HIV infection of the brain but represents the effect of other deleterious inutero and perinatal factors such as exposure to drugs, prematurity and other infections. 7 The main features of progressive encephalopathy are developmental delay, including language retardation, an impaired growth curve and a high rate of pyramidal dysfunction. Eventual severe cognitive decline and progression to a spastic quadriparetic state usually occurs, if systemic conditions allow a long enough period of survival.
No clear-cut cases of peripheral nerve involvement have been described in HIV-infected children. This differs markedly from the findings in the adult AIDS-population, in which at least 15% of patients are symptomatic of peripheral nervous system involvement, this figure reaching 60% in electrophysiological or histological studies. 14 Brain atrophy on CT appears to be an almost universal finding in children with progressive encephalopathy. 4 " 6 Calcifications of the basal ganglia carry an ominous prognosis. 8 We have observed this finding in our series of patients, one notable exception being a 9-year-old asymptomatic child with cerebral atrophy and basal ganglia calcifications observed on CT.
We found a higher than expected rate of abnormal EEGs (67%) and increased CSF protein count (45%) in children with progressive encephalopathy although these changes were not specific.
Neoplasms of the central nervous system and particularly lymphoma have been recognized in HIV-infected children, 7   -8   -10 albeit at a much lower rate than in the adult HIV population where primary CNS lymphoma is found in 1-2% of patients. 15 No neoplasms were found in our patients. We expect however to see more of these complications as the patients become older. Presently, 20% of the 49 patients have reached five years of age. This represents 40% of the living patients. Cerebrovascular complications have been described in children with HIV infection. 810 Ischemic infarcts occur, as do intracerebral hemorrhages, the latter mostly in the context of thrombocytopenia. Only one of our patients suffered a vascular event, a major ischemic stroke.
The most common pathological observations in our patients, HIV encephalitis and corticospinal tract degeneration, are in concordance with the usual findings in HIV infected children. 7101617 Vacuolar myelopathy is a frequently noted finding in the adult population, occurring in some 22% of patients in an autopsy series 18 but is seldomly found in the pediatric HIV population. 17 Three pathologically documented cases of central nervous system opportunistic infections were observed (two CMV cases, one Candida Albicans case). Though much less frequent than in the adult HIV population, neurological opportunistic infections do occur in HIV-infected children.
7 - 8 The association of HIV and CMV is well known, both in neurological and systemic infections. Candida Albicans and toxoplasmosis infections have been reported before, 7 -8 although the latter is generally a congenital condition, acquired infections being rare. 19 By comparison, the clinical picture of HIV-infection in adults is dominated by opportunistic infections, the most frequent being cerebral toxoplasma, occurring in some 25-30% of patients. 15 Other frequently encountered pathogens in adults include Cryptococcus neoformans, the JC virus (progressive multifocal encephalopathy) and viruses of the Herpes family.
CONCLUSIONS
The results of this series are generally in concordance with current data on neurological impairment in children with HIV infection. The percentage of central nervous system involvement is high and the majority of those affected present with a progressive encephalopathy. Cognitive development and growth are frequently further impaired by concommitant systemic diseases.
Unfortunately, the incidence of HIV infection in children continues to increase and the prognosis remains somber. More research is needed to help elucidate the pathophysiology implicated in the different sub-types of encephalopathy. A multidisciplinary approach is obviously of critical importance in the investigation of this complex disease state.
